Literature DB >> 8621673

Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets.

A B MacKenzie1, M P Mahaut-Smith, S O Sage.   

Abstract

We have investigated the purinoceptor subtypes responsible for calcium signaling in human platelets, which previous studies have shown to involve both Ca2+ influx via receptor-operated cation channels and release of Ca2+ from intracellular stores. Fura-2 measurements of [Ca2+]i in stirred platelet suspensions showed that both ADP (40 microM) and the non-hydrolyzable ATP analogue alphabeta-meATP (alpha, beta-methyleneadenosine 5-triphosphate, 10 microM) activated a rapid Ca2+ influx whereas only ADP mobilized Ca2+ from internal stores. In "nystatin" whole-cell patch clamp recordings, ATP, ADP, and the non-hydrolyzable ATP analogues, alpha, beta-meATP and ATPgammaS (adenosine 5 -O-(3-thiotriphosphate), all activated a cation channel permeable to both monovalent and divalent cations with a single-channel conductance of 11 picosiemens in NaCl saline. The current response to ATP (40 microM) was activated within 20 ms and desensitized with a time constant of 47-107 ms in the continued presence of agonist, which are characteristics of P2X1 receptors in other tissues. We conclude that human platelets possess a P2X1 purinoceptor, which mediates a rapid phase of ADP- or ATP-evoked Ca2+ entry via a cation channel, whereas one or more separate ADP-selective P2 purinoceptors evoke release of calcium from intracellular stores.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621673     DOI: 10.1074/jbc.271.6.2879

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  More pieces of the platelet activation puzzle slide into place.

Authors:  L F Brass
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  ADP and platelets: the end of the beginning.

Authors:  D Woulfe; J Yang; L Brass
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 4.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

5.  Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

6.  Historical perspective on ADP-induced platelet activation.

Authors:  Marian A Packham; Margaret L Rand
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

7.  Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.

Authors:  A Sugidachi; F Asai; K Yoneda; R Iwamura; T Ogawa; K Otsuguro; H Koike
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

8.  ADP and inositol trisphosphate evoke oscillations of a monovalent cation conductance in rat megakaryocytes.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1998-09-15       Impact factor: 5.182

9.  cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases.

Authors:  S Tertyshnikova; X Yan; A Fein
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

Review 10.  Harnessing the platelet signaling network to produce an optimal hemostatic response.

Authors:  Lawrence F Brass; Maurizio Tomaiuolo; Timothy J Stalker
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-11       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.